Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Taurine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Taurine SCHEMBL29400164 | 1.00 | ALDH1A1 (0.68) | — | |
| Taurine SCHEMBL29403235 | 1.00 | ALDH1A1 (0.68) | — | |
| Taurine SCHEMBL10626131 | 0.93 | LMNA (0.60) | — | |
| Taurine SCHEMBL688315 | 0.93 | — | — | |
| Taurine SCHEMBL29475753 | 0.93 | LMNA (0.60) | — | |
| Taurine SCHEMBL1100955 | 0.93 | — | — | |
| Taurine SCHEMBL2288742 | 0.93 | LMNA (0.60) | — | |
| Taurine SCHEMBL7107906 | 0.93 | LMNA (0.60) | — | |
| Taurine SCHEMBL10952592 | 0.93 | — | — | |
| Taurine SCHEMBL30097994 | 0.93 | LMNA (0.60) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1529 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746976-A1 | COSMETIC COMPOSITION COMPRISING AT LEAST ONE ALKANOLAMINE, AT LEAST ONE AMINO ACID, AND AT LEAST ONE ALKALI METAL OR ALKALINE EARTH METAL OR AMMONIUM HYDROXIDE | L'OREAL (FR) | 2026-05-27 | — | — | EP | claimed |
| EP-4746975-A1 | METHOD FOR SMOOTHING KERATIN FIBRES | L'OREAL (FR) | 2026-05-27 | — | — | EP | claimed |
| CN-116249536-B | Batch production method of sodium taurodeoxycholate | 沙裴隆有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122056386-A | Moisture absorption resistant slow release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122030612-A | Shear-resistant slow-release microcapsule powder and preparation method and application thereof | 大连医诺生物股份有限公司 | 2026-05-15 | — | — | CN | claimed |
| US-20260042080-A1 | SOLID SORBENT FOR REMOVAL OF CARBON DIOXIDE FROM A CO2-CONTAINING GAS | SUSTAERA INC (US) | 2026-02-12 | — | — | US | claimed |
| EP-4651974-A2 | SOLID SORBENT FOR REMOVAL OF CARBON DIOXIDE FROM A CO2-CONTAINING GAS | Sustaera Inc. (US) | 2025-11-26 | — | — | EP | claimed |
| EP-4630398-A1 | N-ACYL AMINOALKANE SULFONATE SURFACTANTS AND DERIVATIVES THEREOF | The Procter & Gamble Company (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4282856-B1 | METHOD FOR PREPARING TAURINE | ZHEJIANG NHU PHARMACEUTICAL CO LTD (CN) | 2025-09-10 | — | — | EP | claimed |
| US-20250248951-A1 | ESKETAMINE LIQUID PREPARATION AND USE THEREOF | Yichang Humanwell Pharmaceutical Co., Ltd. (CN) | 2025-08-07 | — | — | US | claimed |
| CN-100335056-C | Pharmaceutical composition and its application in preparation of medicine for treating type II diabetes | TIANJIN INST PHARM RESEARCH (CN) | 2007-09-05 | — | — | CN | claimed |
| US-20060127338-A1 | Aqueous suspensions of cross-linked silicone particles, aqueous emulsions of oil containing cross-linked silicone particles, and cosmetic raw material | DOW CORNING TORAY COMPANY, LTD. (JP) | 2006-06-15 | — | — | US | claimed |
| CN-1762356-A | Pharmaceutical composition and its application in preparation of medicine for treating type II diabetes | TIANJIN INST PHARM RESEARCH (CN) | 2006-04-26 | — | — | CN | claimed |
| CN-1670115-A | Polishing composition and polishing method | FUJIMI INC (JP) | 2005-09-21 | — | — | CN | claimed |
| CN-1647639-A | Composition for preventing straw-berry weeds and its preparing method and use | SHANGHAI CITY PESTICIDE RES IN (CN) | 2005-08-03 | — | — | CN | claimed |
| EP-1054664-A1 | METHOD FOR MODULATING MACROPHAGE ACTIVATION | Neurochem, Inc. (CA) | 2000-11-29 | — | — | EP | claimed |
| CN-1234821-A | Corrosion inhibitor for wellbore application | PHILLIPS PETROLEUM CO (US) | 1999-11-10 | — | — | CN | claimed |
| WO-1999040909-A1 | METHOD FOR MODULATING MACROPHAGE ACTIVATION | NEUROCHEM, INC. (CA) | 1999-08-19 | — | — | WO | claimed |
| CN-1098091-A | Arylalkylamide ethanesulfonic acid and preparation thereof are used | GUANGDONG MEDICAL AND PHARMIC (CN) | 1995-02-01 | — | — | CN | claimed |
| US-3931118-A | FIBERS | PHILLIPS PETROLEUM COMPANY (US) | 1976-01-06 | — | — | US | claimed |